These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6313463)
21. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis. Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638 [TBL] [Abstract][Full Text] [Related]
22. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465 [TBL] [Abstract][Full Text] [Related]
23. [Primary cancer of the liver in Vizcaya. Necropsic study]. del Villar Negro A; Merino Angulo J; Ortega F; Rivera Pomar JM Rev Clin Esp; 1983 Nov; 171(4):277-80. PubMed ID: 6320317 [No Abstract] [Full Text] [Related]
24. [Assay of estradiol receptors in a liver adenoma observed after taking an estrogen-progestogen combination]. Gastard J; Gosselin M; Bretagne JF; Hannouche N; Samperez S; Jouan P; Launois B Nouv Presse Med; 1980 Jan; 9(1):43. PubMed ID: 7355068 [TBL] [Abstract][Full Text] [Related]
25. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms. Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251 [TBL] [Abstract][Full Text] [Related]
26. [Hormone receptors and precancerous lesions of the breast]. Mignot L; Espie M; de Roquancourt A; Gorins A Pathol Biol (Paris); 1983 Nov; 31(9):761-4. PubMed ID: 6318180 [TBL] [Abstract][Full Text] [Related]
27. In vitro binding of 3H-estradiol to eosinophil and neutrophil granulocytes in various tissues (normal and neoplastic) of newborn and adult rats. Geuskens M; Burglen MJ; Uriel J Virchows Arch B Cell Pathol; 1977 May; 24(1):67-78. PubMed ID: 194390 [TBL] [Abstract][Full Text] [Related]
29. [Substantial increase in primary liver cancer in women in Gothenburg]. Kaczynski J; Wallerstedt S; Hansson G Lakartidningen; 1983 Nov; 80(46):4400-1. PubMed ID: 6318002 [No Abstract] [Full Text] [Related]
30. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [TBL] [Abstract][Full Text] [Related]
31. [Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?]. Kreysel C; Porschen R Z Gastroenterol; 1998 Jul; 36(7):605-7. PubMed ID: 9738309 [No Abstract] [Full Text] [Related]
32. A resected case of a small hepatocellular carcinoma developing within the bile duct. Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893 [TBL] [Abstract][Full Text] [Related]
33. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease. Villa E; Dugani A; Moles A; Camellini L; Grottola A; Buttafoco P; Merighi A; Ferretti I; Esposito P; Miglioli L; Bagni A; Troisi R; De Hemptinne B; Praet M; Callea F; Manenti F Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437 [TBL] [Abstract][Full Text] [Related]
34. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones". Hunt JP; Varnholt H Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649 [No Abstract] [Full Text] [Related]
35. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma. Zimmerman RL; Fogt F; Burke M; Murakata LA Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193 [TBL] [Abstract][Full Text] [Related]
36. [Study of estrogen receptors in hepatocellular carcinoma and its response to anti-estrogen therapy]. Zheng T; Zhang Q; Xie Z Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):451-3. PubMed ID: 10920881 [TBL] [Abstract][Full Text] [Related]
37. [Prognostic significance of the analysis of estradiol receptor activity in tumor tissue of patients with primary breast carcinoma]. Raemaekers JM; Beex LV; Koenders AJ; Smals AG; Pieters GF; Benraad TJ; Kloppenborg PW Ned Tijdschr Geneeskd; 1982 Aug; 126(33):1493-8. PubMed ID: 7133188 [No Abstract] [Full Text] [Related]
38. [Establishment of an estrogen receptor positive 3'-methyl-4-dimethylaminoazobenzene induced hepatoma cell line of rat and investigation of hormonal therapy]. Kameda H Hokkaido Igaku Zasshi; 1996 Nov; 71(6):711-26. PubMed ID: 8996840 [TBL] [Abstract][Full Text] [Related]
39. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Villa E; Moles A; Ferretti I; Buttafoco P; Grottola A; Del Buono M; De Santis M; Manenti F Hepatology; 2000 Aug; 32(2):233-8. PubMed ID: 10915729 [TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma originating from intramural cells in the bile duct. Hasegawa K; Kubota K; Mori M; Midorikawa Y; Takayama T; Makuuchi M Hepatogastroenterology; 2002; 49(48):1688-91. PubMed ID: 12397767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]